ARB Compared with non-ARB in Preventing Cardiac Events in High Risk Hypertensive Patients: An Evidence Based Case Report
Background: High risk hypertensive patients have an increased risk of developing cardiovascular complication. It is better to use a proven cardio protective drugs to reduce blood pressure in high risk hypertensive patients. Angiotensin II receptor Blocker (ARB) is one type of antihyper-tensive drugs...
Main Authors: | Alvin Nursalim, Yoga Yuniadi |
---|---|
Format: | Article |
Language: | English |
Published: |
Indonesian Heart Association
2013-06-01
|
Series: | Majalah Kardiologi Indonesia |
Subjects: | |
Online Access: | http://ijconline.id/index.php/ijc/article/view/59 |
Similar Items
-
Effect of ACEi and ARBs vs Non ACEi/ARBs in Hypertension with Respect to Renal Outcomes in COVID-19 Infection: A Retrospective Cohort Study
by: S Ravitej, et al.
Published: (2022-11-01) -
Possibilities ARB II (sartans) in hypertensive patients
by: T E Morozova, et al.
Published: (2014-09-01) -
ARNI versus ACEI/ARB in Reducing Cardiovascular Outcomes after Myocardial Infarction
by: Jianqing She, et al.
Published: (2021-12-01) -
Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension
by: Jing Ma, et al.
Published: (2021-05-01) -
Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials
by: Ruxin Wang, et al.
Published: (2022-12-01)